Home > Insider Trading > Filing (0001562180-20-007111)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573574	Anita Pramoda	C/O Health Catalyst, Inc. 3165 Millrock Drive, #400 Salt Lake City, UT 84121		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-07	12,000	$10.40	17,443	No	4	M	Direct
Common Stock	Disposition	2020-12-07	12,000	$38.18	5,443	No	4	S	Direct
Common Stock	Disposition	2020-12-07	22,000	$38.11	8,348	No	4	S	Indirect	By Omkara, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By Omkara, LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-12-07	12,000	$0.00	12,000	$10.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
50,500	2020-04-28	2026-04-28	No	4	M	Direct

Footnotes

The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 14, 2019, in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $38.00 to $38.69, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held by Omkara, LLC and the Reporting Person wholly-owns and holds the voting and dispositive power of these shares.
25% of the 62,500 shares underlying the options vested in an annual installment on April 28, 2017 and the remaining balance vested in equal monthly installments until the option vested in full on April 28, 2020.